Back to Search
Start Over
Pharmacogenomics: Relevance and opportunities for clinical pharmacology.
- Source :
-
British Journal of Clinical Pharmacology . Sep2022, Vol. 88 Issue 9, p3943-3946. 4p. - Publication Year :
- 2022
-
Abstract
- Pharmacogenonomics (PGx) is the intersection of genomic medicine and pharmacology whereby knowledge of variation in an individual's genome is utilized to inform prescribing practice. In conclusion, PGx represents a novel piece in the jigsaw of factors that should be collectively considered when developing novel drugs and prescribing current drugs to improve the safety and efficacy of pharmacotherapy. For instance, it is possible that some clinical pharmacologists with a particular interest in PGx may become PGx specialists, similar to how some clinical pharmacologists have specialized in hypertension or clinical toxicology. [Extracted from the article]
Details
- Language :
- English
- ISSN :
- 03065251
- Volume :
- 88
- Issue :
- 9
- Database :
- Academic Search Index
- Journal :
- British Journal of Clinical Pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 158601529
- Full Text :
- https://doi.org/10.1111/bcp.15329